PERCEPTIVE ADVISORS LLC
Insider CIK 1224962 · CEMI 10% owner · SCYX 10% owner · FOLD 10% owner · AGRX 10% owner · ATNX 10% owner · ALBO 10% owner · LYRA Director, 10% owner · AEGR 10% owner · ALDX 10% owner · ADMA 10% owner · ZGNX 10% owner · ACRX 10% owner · CATB Director, 10% owner · SLNO 10% owner · LPTX 10% owner · VSAR 10% owner · KDMN · MNLO 10% owner · CORI 10% owner · QTNT 10% owner · ISO 10% owner · LONA Director, 10% owner · GBT 10% owner · CRNX Director, 10% owner · VRCA 10% owner · DOVA 10% owner · MOTS 10% owner · SLDB Director, 10% owner · RXDX 10% owner · RAIN 10% owner · MGTX Director, 10% owner · ACRV 10% owner · LABP Director, 10% owner · CERE Director · NAUT Director, 10% owner · IMTX Director · OBIO 10% owner · LIAN Director, 10% owner · CRGX · ADGM Director, 10% owner · FRNM 10% owner · KARD Director · VBIV 10% owner · VBIV 10% owner · RPRX 10% owner · LJPC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LONA LeonaBio, Inc. | M Exercise deriv | 2026-10-26 | 2026-10-26 | 776,648 | — | — | 0 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise | 2026-10-26 | 2026-10-26 | 776,648 | $0.00 | $777 | 776,648 | SEC↗ |
| IMTX Immatics N.V. | P Buy | 2026-08-26 | 2026-08-27 | 863,060 | $8.69 | $7.50M | 11,246,516 | SEC↗ |
| IMTX Immatics N.V. | P Buy | 2026-08-26 | 2026-08-27 | 863,060 | $8.69 | $7.50M | 11,246,516 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 5,500,000 | $10.00 | $55.00M | 10,871,847 | SEC↗ |
| LONA LeonaBio, Inc. | A Award deriv | 2026-06-23 | 2026-07-09 | 28,000 | — | $0 | 28,000 | SEC↗ |
| KARD Kardigan, Inc. | A Award | 2026-06-17 | 2026-07-13 | 20,706 | — | $0 | 20,706 | SEC↗ |
| IMTX Immatics N.V. | A Award deriv | 2026-06-16 | 2026-06-18 | 48,000 | — | $0 | 48,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2026-06-11 | 2026-06-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 77,500 | — | $0 | 77,500 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award | 2026-04-17 | 2026-04-23 | 555,555 | $9.00 | $5.00M | 10,786,658 | SEC↗ |
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-07-10 | 28,000 | — | $0 | 28,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2026-03-25 | 2026-04-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | D To issuer deriv | 2026-03-25 | 2026-04-23 | 400,000 | — | $0 | 0 | SEC↗ |
| MGTX MeiraGTx Holdings plc | D To issuer deriv | 2026-03-25 | 2026-04-23 | 300,000 | — | $0 | 0 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2026-03-25 | 2026-04-23 | 400,000 | — | $0 | 400,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-03-09 | 2026-03-11 | 8,912,655 | $5.61 | $50.00M | 8,912,655 | SEC↗ |
| MGTX MeiraGTx Holdings plc | D To issuer | 2025-12-31 | 2026-01-02 | 2,300,000 | $7.91 | $18.19M | 10,231,103 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-23 | 2025-12-23 | 1,279,526 | $6.35 | $8.12M | 1,279,526 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-23 | 2025-12-23 | 1,372,935 | $6.35 | $8.72M | 1,372,935 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-23 | 2025-12-23 | 3,838,583 | $6.35 | $24.38M | 3,838,583 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-23 | 2025-12-23 | 3,543,307 | $6.35 | $22.50M | 3,543,307 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-23 | 2025-12-23 | 457,645 | $6.35 | $2.91M | 457,645 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-23 | 2025-12-23 | 1,181,101 | $6.35 | $7.50M | 1,181,101 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-23 | 2025-12-23 | 5,502,402 | — | $0 | 5,502,402 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2025-12-23 | 2025-12-23 | 329,756 | $6.35 | $2.09M | 329,756 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2025-12-23 | 2025-12-23 | 989,270 | $6.35 | $6.28M | 1,529,566 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-13 | 2025-11-13 | 3,213 | $3.90 | $12.5K | 14,026 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-13 | 2025-11-13 | 28,597 | $3.90 | $111.5K | 124,859 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-12 | 2025-11-13 | 7,862 | $4.06 | $31.9K | 153,456 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-12 | 2025-11-13 | 883 | $4.06 | $3.6K | 17,239 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-11 | 2025-11-13 | 4,783 | $4.31 | $20.6K | 161,318 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-11 | 2025-11-13 | 537 | $4.31 | $2.3K | 18,122 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-10 | 2025-11-10 | 16,633 | $4.54 | $75.5K | 166,101 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-10 | 2025-11-10 | 1,869 | $4.54 | $8.5K | 18,659 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 17,746 | $4.75 | $84.3K | 182,734 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 1,993 | $4.75 | $9.5K | 20,528 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 3,247 | $5.18 | $16.8K | 22,521 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 28,902 | $5.18 | $149.7K | 200,480 | SEC↗ |
| ADGM Adagio Medical Holdings, I | P Buy deriv | 2025-10-20 | 2025-10-22 | 1,344,999 | $0.18 | $242.1K | 1,344,999 | SEC↗ |
| ADGM Adagio Medical Holdings, I | P Buy deriv | 2025-10-20 | 2025-10-22 | 1,344,999 | $0.18 | $242.1K | 1,344,999 | SEC↗ |
| ADGM Adagio Medical Holdings, I | P Buy deriv | 2025-10-20 | 2025-10-22 | 2,190,496 | $1.60 | $3.50M | 2,190,496 | SEC↗ |
| ADGM Adagio Medical Holdings, I | P Buy deriv | 2025-10-20 | 2025-10-22 | 1,344,999 | $0.18 | $242.1K | 1,344,999 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | P Buy deriv | 2025-08-01 | 2025-08-05 | 1,500,000 | $2.75 | $4.13M | 1,500,000 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | P Buy | 2025-08-01 | 2025-08-05 | 700,000 | $2.75 | $1.93M | 5,292,556 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 77,500 | — | $0 | 77,500 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2025-06-12 | 2025-06-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2025-05-01 | 2025-05-01 | 298,886 | $1.34 | $400.5K | 3,104,139 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2025-04-30 | 2025-05-01 | 437,881 | $1.41 | $617.4K | 3,403,025 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2025-04-29 | 2025-04-29 | 250,000 | $1.41 | $352.5K | 3,840,906 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2025-04-28 | 2025-04-29 | 215,283 | $1.56 | $335.8K | 4,090,906 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2025-04-25 | 2025-04-29 | 1,054,669 | $1.95 | $2.06M | 4,306,189 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | S Sale | 2025-04-03 | 2025-04-07 | 3,400,000 | $1.42 | $4.83M | 5,875,851 | SEC↗ |
| SLDB Solid Biosciences Inc. | P Buy | 2025-02-19 | 2025-02-21 | 5,000,000 | $4.03 | $20.15M | 11,833,539 | SEC↗ |
| ADGM Adagio Medical Holdings, I | A Award | 2025-01-22 | 2025-02-14 | 64,167 | — | $0 | 9,675,684 | SEC↗ |
| MGTX MeiraGTx Holdings plc | P Buy | 2024-08-12 | 2024-08-14 | 1,250,000 | $4.00 | $5.00M | 12,531,103 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2024-06-14 | 2024-06-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2024-06-11 | 2024-11-19 | 34,400 | — | $0 | 34,400 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2024-06-06 | 2024-06-07 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | P Buy | 2024-04-11 | 2024-04-15 | 2,353,000 | $8.50 | $20.00M | 5,360,858 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2024-04-05 | 2024-04-08 | 37,712 | $4.74 | $178.8K | 9,275,851 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2024-04-04 | 2024-04-08 | 140,281 | $4.67 | $655.1K | 9,238,139 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2024-04-03 | 2024-04-03 | 309,847 | $4.09 | $1.27M | 9,097,858 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2024-04-02 | 2024-04-03 | 186,051 | $3.44 | $640.0K | 8,788,011 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2024-04-01 | 2024-04-03 | 8,374 | $3.25 | $27.2K | 8,601,960 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | G Gift | 2024-02-20 | 2024-02-21 | 170,317 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | M Exercise deriv | 2024-02-15 | 2024-02-20 | 36,300 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | M Exercise deriv | 2024-02-15 | 2024-02-20 | 36,300 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | F Tax w/h | 2024-02-15 | 2024-02-20 | 19,218 | $4.76 | $91.5K | 17,082 | SEC↗ |
| LIAN LianBio | F Tax w/h | 2024-02-15 | 2024-02-20 | 19,218 | $4.76 | $91.5K | 17,082 | SEC↗ |
| LIAN LianBio | M Exercise | 2024-02-15 | 2024-02-20 | 36,300 | $2.52 | $91.5K | 36,300 | SEC↗ |
| LIAN LianBio | M Exercise | 2024-02-15 | 2024-02-20 | 36,300 | $2.52 | $91.5K | 36,300 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2024-02-01 | 2024-02-05 | 2,481,350 | $12.09 | $30.00M | 4,873,721 | SEC↗ |
| SLDB Solid Biosciences Inc. | P Buy | 2024-01-11 | 2024-01-12 | 3,410,713 | $5.53 | $18.86M | 6,833,539 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-12-29 | 2023-12-29 | 163,954 | $2.38 | $390.2K | 5,402,964 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-29 | 2023-12-29 | 115,774 | $7.24 | $838.2K | 7,099,182 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-12-28 | 2023-12-29 | 409,598 | $2.44 | $999.4K | 5,239,010 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-28 | 2023-12-29 | 126,116 | $7.08 | $892.9K | 6,983,408 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-12-27 | 2023-12-29 | 32,134 | $2.28 | $73.3K | 4,829,412 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-27 | 2023-12-29 | 79,726 | $7.20 | $574.0K | 6,857,292 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-26 | 2023-12-26 | 54,652 | $6.49 | $354.7K | 6,777,566 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-22 | 2023-12-26 | 250,000 | $6.67 | $1.67M | 6,722,914 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2023-12-21 | 2023-12-22 | 740,000 | $6.20 | $4.59M | 2,392,371 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-21 | 2023-12-26 | 200,000 | $6.17 | $1.23M | 6,472,914 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-19 | 2023-12-19 | 277,008 | $5.36 | $1.48M | 6,272,914 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-18 | 2023-12-19 | 456,923 | $5.41 | $2.47M | 5,995,906 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-12-15 | 2023-12-19 | 500,000 | $5.97 | $2.98M | 5,538,983 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-14 | 2,579,502 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion | 2023-11-14 | 2023-11-14 | 2,579,502 | — | $0 | 2,579,502 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-14 | 333,333 | $15.00 | $5.00M | 333,333 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-14 | 333,333 | $15.00 | $5.00M | 2,912,835 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | S Sale | 2023-10-18 | 2023-10-18 | 306,499 | $1.74 | $533.3K | 8,593,586 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 614,062 | $6.51 | $4.00M | 460,546 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 921,093 | $6.51 | $6.00M | 1,151,366 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 921,093 | $6.51 | $6.00M | 921,093 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy deriv | 2023-10-16 | 2023-10-18 | 460,546 | $6.51 | $3.00M | 345,409 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2023-10-16 | 2023-10-17 | 876,808 | $22.81 | $20.00M | 10,794,876 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-18 | 460,546 | $6.51 | $3.00M | 1,611,699 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-18 | 614,062 | $6.51 | $4.00M | 1,652,371 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | S Sale | 2023-10-16 | 2023-10-18 | 2,450,000 | $1.60 | $3.92M | 8,900,085 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy deriv | 2023-09-28 | 2023-09-28 | 250,000 | $19.99 | $5.00M | 250,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-28 | 2023-09-28 | 250,000 | $20.00 | $5.00M | 3,074,542 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 75,477 | $17.28 | $1.30M | 2,528,231 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 27,769 | $16.00 | $444.3K | 2,452,754 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 3,326 | $14.61 | $48.6K | 2,424,985 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 30,511 | $13.92 | $424.7K | 2,421,659 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 42,838 | $12.84 | $550.0K | 2,391,148 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 77,837 | $11.81 | $919.3K | 2,348,310 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 37,911 | $11.05 | $418.9K | 2,270,473 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 5,419 | $9.52 | $51.6K | 2,232,562 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 52,691 | $18.24 | $961.1K | 2,580,922 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 88,685 | $19.11 | $1.69M | 2,669,607 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 117,996 | $20.03 | $2.36M | 2,787,603 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 36,939 | $21.00 | $775.7K | 2,824,542 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 13,687 | $8.30 | $113.6K | 2,227,143 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-09-26 | 2023-09-28 | 5,703 | $7.65 | $43.6K | 2,213,456 | SEC↗ |
| LIAN LianBio | A Award deriv | 2023-06-21 | 2023-06-23 | 36,300 | — | $0 | 36,300 | SEC↗ |
| LIAN LianBio | A Award deriv | 2023-06-21 | 2023-06-23 | 36,300 | — | $0 | 36,300 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2023-06-15 | 2023-06-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2023-06-08 | 2023-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2023-06-08 | 2023-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 9,650 | — | $0 | 9,650 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-06-06 | 2023-06-06 | 200 | $5.93 | $1.2K | 2,207,753 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-06-05 | 2023-06-06 | 78,468 | $5.98 | $469.2K | 2,207,553 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-06-02 | 2023-06-06 | 64,630 | $5.93 | $383.3K | 2,129,085 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-06-01 | 2023-06-01 | 7,500 | $5.59 | $41.9K | 2,064,455 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy deriv | 2023-05-31 | 2023-06-02 | 1,805,416 | — | $0 | 1,805,416 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-31 | 2023-06-01 | 10,000 | $5.28 | $52.8K | 2,056,955 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2023-05-31 | 2023-06-02 | 3,610,832 | $2.49 | $8.99M | 11,469,117 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-30 | 2023-06-01 | 17,500 | $5.34 | $93.5K | 2,046,955 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-26 | 2023-05-26 | 22,500 | $5.27 | $118.6K | 2,029,455 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-25 | 2023-05-26 | 37,500 | $5.18 | $194.3K | 2,006,955 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-24 | 2023-05-26 | 25,000 | $5.48 | $137.0K | 1,969,455 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-23 | 2023-05-23 | 27,500 | $5.45 | $149.9K | 1,944,455 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-22 | 2023-05-23 | 27,300 | $5.12 | $139.8K | 1,916,955 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2023-05-19 | 2023-05-23 | 25,200 | $4.62 | $116.4K | 1,889,655 | SEC↗ |
| MGTX MeiraGTx Holdings plc | P Buy | 2023-05-05 | 2023-05-15 | 4,347,826 | $5.75 | $25.00M | 11,281,103 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | U Tender | 2023-04-27 | 2023-05-01 | 5,162,782 | $0.45 | $2.32M | 0 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-25 | 2023-04-25 | 133,742 | $0.45 | $60.2K | 5,162,782 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-24 | 2023-04-25 | 39,506 | $0.45 | $17.8K | 5,029,040 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-21 | 2023-04-25 | 70,200 | $0.45 | $31.6K | 4,989,534 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-20 | 2023-04-20 | 56,000 | $0.45 | $25.2K | 4,919,334 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-19 | 2023-04-20 | 137,000 | $0.45 | $61.6K | 4,863,334 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-18 | 2023-04-20 | 15,800 | $0.45 | $7.1K | 4,726,334 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-17 | 2023-04-17 | 4,800 | $0.45 | $2.2K | 4,710,534 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-14 | 2023-04-17 | 11,500 | $0.45 | $5.2K | 4,705,734 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-13 | 2023-04-17 | 140,134 | $0.45 | $63.1K | 4,694,234 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-11 | 2023-04-13 | 129,000 | $0.44 | $56.8K | 4,554,100 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2023-04-06 | 2023-04-06 | 4,251,563 | $0.11 | $467.7K | 41,440,729 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-06 | 2023-04-06 | 339,000 | $0.44 | $149.2K | 4,425,100 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2023-04-05 | 2023-04-06 | 1,832,563 | $0.13 | $238.2K | 45,691,816 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-05 | 2023-04-06 | 217,500 | $0.45 | $97.9K | 4,086,100 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2023-04-04 | 2023-04-06 | 4,810,623 | $0.16 | $769.7K | 47,524,379 | SEC↗ |
| CEMI CHEMBIO DIAGNOSTICS, INC. | P Buy | 2023-04-04 | 2023-04-06 | 195,938 | $0.44 | $86.2K | 3,868,600 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy deriv | 2023-01-10 | 2023-01-11 | 3,636,363 | $0.54 | $1.96M | 3,636,363 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy deriv | 2023-01-10 | 2023-01-11 | 27,272,727 | $0.54 | $14.73M | 27,272,727 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2022-12-19 | 2022-12-21 | 908,265 | $11.01 | $10.00M | 1,038,309 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-13 | 2022-12-15 | 9,650 | — | $0 | 9,650 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-06 | 73,107 | — | $0 | 73,107 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-06 | 2,163,120 | $7.05 | $15.25M | 3,057,290 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-06 | 365,536 | — | $0 | 3,422,826 | SEC↗ |
| QTNT Quotient Ltd | S Sale | 2022-10-31 | 2022-11-02 | 8,255,607 | $0.08 | $660.4K | 7,945,211 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-13 | 2022-10-13 | 178,726 | $22.01 | $3.93M | 1,940,129 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-13 | 2022-10-13 | 406 | $22.79 | $9.3K | 1,939,723 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-12 | 2022-10-13 | 89,979 | $22.26 | $2.00M | 2,126,095 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-12 | 2022-10-13 | 7,240 | $23.23 | $168.2K | 2,118,855 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-11 | 2022-10-13 | 38,310 | $24.18 | $926.3K | 2,221,489 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-11 | 2022-10-13 | 5,415 | $24.78 | $134.2K | 2,216,074 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-11 | 2022-10-13 | 100,340 | $23.23 | $2.33M | 2,259,799 | SEC↗ |
| LIAN LianBio | P Buy | 2022-08-18 | 2022-08-22 | 998,240 | $2.40 | $2.40M | 3,728,491 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy deriv | 2022-08-16 | 2022-08-18 | 0 | $100000000.00 | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2022-08-16 | 2022-08-18 | 1,425,000 | $35.00 | $49.88M | 6,511,727 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-10 | 2022-08-11 | 15,000 | $7.85 | $117.8K | 11,350,085 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-09 | 2022-08-11 | 100,000 | $7.50 | $750.0K | 11,335,085 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-08 | 2022-08-10 | 97,000 | $7.24 | $702.3K | 11,235,085 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-05 | 2022-08-09 | 141,000 | $6.95 | $980.0K | 11,138,085 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-04 | 2022-08-08 | 95,100 | $6.17 | $586.8K | 10,997,085 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-03 | 2022-08-05 | 100,000 | $5.84 | $584.0K | 10,901,985 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2022-08-02 | 2026-04-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2022-08-02 | 2026-04-23 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-02 | 2022-08-04 | 412,406 | $5.59 | $2.31M | 10,801,985 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-08-01 | 2022-08-03 | 144,185 | $5.05 | $728.1K | 10,389,579 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-07-29 | 2022-08-02 | 222,123 | $5.03 | $1.12M | 10,245,394 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-07-28 | 2022-08-01 | 119,392 | $5.00 | $597.0K | 10,023,271 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2022-07-05 | 2022-07-05 | 1,428,571 | $2.10 | $3.00M | 5,038,983 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2022-06-30 | 2022-07-01 | 1,101,362 | $2.99 | $3.29M | 4,797,278 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2022-06-29 | 2022-07-01 | 270,000 | $2.99 | $807.3K | 3,695,916 | SEC↗ |
| LIAN LianBio | A Award deriv | 2022-06-23 | 2022-06-27 | 36,000 | — | $0 | 36,000 | SEC↗ |
| LIAN LianBio | A Award deriv | 2022-06-23 | 2022-06-27 | 36,000 | — | $0 | 36,000 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2022-06-15 | 2022-06-17 | 86,467 | — | $0 | 86,467 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 51,000 | — | $0 | 51,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2022-06-07 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2022-06-07 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-26 | 2022-05-27 | 69,000 | $3.13 | $216.0K | 2,730,251 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-25 | 2022-05-25 | 120,000 | $2.63 | $315.6K | 2,661,251 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-24 | 2022-05-25 | 42,551 | $2.47 | $105.1K | 2,541,251 | SEC↗ |
| LIAN LianBio | P Buy | 2022-05-23 | 2022-05-25 | 8,700 | $2.49 | $21.7K | 2,498,700 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-05-20 | 2022-05-27 | 13,871 | — | $0 | 13,871 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2022-04-18 | 2022-04-18 | 157,515 | $22.22 | $3.50M | 5,321,032 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2022-04-12 | 2022-04-14 | 5,924,170 | $4.22 | $25.00M | 7,858,285 | SEC↗ |
| NAUT Nautilus Biotechnology, In | P Buy | 2021-12-08 | 2021-12-10 | 200,000 | $5.36 | $1.07M | 9,111,151 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2021-12-01 | 2021-12-03 | 2,707,463 | $3.31 | $8.96M | 52,334,993 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 635,369 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 500,000 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion deriv | 2021-11-03 | 2021-11-03 | 423,579 | — | $0 | 0 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 2,477,005 | — | $0 | 2,477,005 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 3,715,510 | — | $0 | 10,969,395 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 14,619,500 | — | $0 | 25,588,895 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 14,619,500 | — | $0 | 21,653,385 | SEC↗ |
| LIAN LianBio | C Conversion | 2021-11-03 | 2021-11-03 | 2,923,000 | — | $0 | 4,330,675 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-03 | 2021-11-05 | 20,000 | $13.51 | $270.2K | 27,858,895 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-03 | 2021-11-05 | 2,250,000 | $16.00 | $36.00M | 27,838,895 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-02 | 2021-11-03 | 100,000 | $13.50 | $1.35M | 7,253,885 | SEC↗ |
| LIAN LianBio | P Buy | 2021-11-01 | 2021-11-03 | 120,000 | $15.50 | $1.86M | 7,153,885 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2021-10-25 | 2021-10-25 | 1,200,000 | $19.80 | $23.76M | 5,163,517 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | P Buy deriv | 2021-10-13 | 2021-10-15 | 2,687,280 | — | $0 | 2,687,280 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | P Buy | 2021-10-13 | 2021-10-15 | 5,734,560 | $0.85 | $4.87M | 21,654,485 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion deriv | 2021-10-12 | 2021-10-14 | 325,014 | — | $0 | 0 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion deriv | 2021-10-12 | 2021-10-14 | 40,373 | — | $0 | 0 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion deriv | 2021-10-12 | 2021-10-14 | 24,629 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | S Sale | 2021-10-12 | 2021-10-13 | 7,306 | $13.40 | $97.9K | 2,487,019 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion | 2021-10-12 | 2021-10-14 | 2,704,587 | — | $0 | 2,704,587 | SEC↗ |
| ISO IsoPlexis Corp | P Buy | 2021-10-12 | 2021-10-14 | 850,000 | $15.00 | $12.75M | 3,554,587 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion | 2021-10-12 | 2021-10-14 | 204,949 | — | $0 | 204,949 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion | 2021-10-12 | 2021-10-14 | 335,962 | — | $0 | 335,962 | SEC↗ |
| RAIN Rain Therapeutics Inc. | S Sale | 2021-10-11 | 2021-10-13 | 9,351 | $13.15 | $123.0K | 2,494,325 | SEC↗ |
| RAIN Rain Therapeutics Inc. | S Sale | 2021-10-11 | 2021-10-13 | 12,475 | $12.03 | $150.1K | 2,503,676 | SEC↗ |
| RAIN Rain Therapeutics Inc. | S Sale | 2021-10-08 | 2021-10-13 | 2,462 | $13.66 | $33.6K | 2,516,151 | SEC↗ |
| RAIN Rain Therapeutics Inc. | S Sale | 2021-10-08 | 2021-10-13 | 5,038 | $12.90 | $65.0K | 2,518,613 | SEC↗ |
| RAIN Rain Therapeutics Inc. | S Sale | 2021-10-07 | 2021-10-13 | 286 | $15.05 | $4.3K | 2,523,651 | SEC↗ |
| RAIN Rain Therapeutics Inc. | S Sale | 2021-10-07 | 2021-10-13 | 13,082 | $14.80 | $193.6K | 2,523,937 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-09-30 | 2021-09-30 | 137,495 | $1.12 | $154.0K | 13,262,375 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-09-29 | 2021-09-30 | 82,505 | $1.16 | $95.7K | 13,399,870 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-09-28 | 2021-09-30 | 40,603 | $1.22 | $49.5K | 13,482,375 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-09-27 | 2021-09-29 | 250,000 | $1.23 | $307.5K | 13,522,978 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | P Buy deriv | 2021-09-24 | 2021-09-28 | 3,508,771 | $2.85 | $10.00M | 3,508,771 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-09-24 | 2021-09-29 | 250,000 | $1.26 | $315.0K | 13,772,978 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-09-23 | 2021-09-28 | 780,000 | $1.27 | $990.6K | 14,022,978 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2021-08-27 | 2021-08-31 | 25,291 | — | $0 | 25,291 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2021-08-26 | 2021-08-31 | 68,047 | $30.23 | $2.06M | 5,086,727 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2021-08-25 | 2021-08-25 | 61,387 | $28.57 | $1.75M | 5,018,680 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2021-08-24 | 2021-08-25 | 69,761 | $27.73 | $1.93M | 4,957,293 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2021-08-23 | 2021-08-25 | 44,437 | $25.78 | $1.15M | 4,887,532 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-08-19 | 2021-08-19 | 350,352 | $1.24 | $434.4K | 14,802,978 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-08-18 | 2021-08-19 | 552,380 | $1.29 | $712.6K | 15,153,330 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | S Sale | 2021-08-17 | 2021-08-19 | 879,092 | $1.35 | $1.19M | 15,705,710 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | S Sale | 2021-08-16 | 2021-08-18 | 250,000 | $1.74 | $435.0K | 4,935,057 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | S Sale | 2021-08-13 | 2021-08-17 | 250,000 | $1.84 | $460.0K | 5,185,057 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | S Sale | 2021-08-12 | 2021-08-16 | 338,897 | $2.23 | $755.7K | 5,435,057 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | P Buy | 2021-07-07 | 2021-07-09 | 200,000 | $25.00 | $5.00M | 4,843,095 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2021-06-29 | 2021-06-30 | 500,709 | $3.80 | $1.90M | 0 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2021-06-29 | 2021-06-30 | 145,548 | $3.80 | $553.1K | 0 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2021-06-10 | 2021-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MGTX MeiraGTx Holdings plc | A Award deriv | 2021-06-10 | 2021-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | X Exercise deriv | 2021-06-09 | 2021-06-11 | 1,602,888 | — | $0 | 0 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | X Exercise deriv | 2021-06-09 | 2021-06-11 | 465,936 | — | $0 | 0 | SEC↗ |
| NAUT Nautilus Biotechnology, In | P Buy | 2021-06-09 | 2021-06-11 | 5,500,000 | $10.00 | $55.00M | 5,997,038 | SEC↗ |
| NAUT Nautilus Biotechnology, In | J Other | 2021-06-09 | 2021-06-11 | 2,914,113 | — | $0 | 8,911,151 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | X Exercise | 2021-06-09 | 2021-06-11 | 465,936 | $2.75 | $1.28M | 465,936 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2021-06-09 | 2021-06-11 | 1,102,179 | $4.00 | $4.41M | 500,709 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | S Sale | 2021-06-09 | 2021-06-11 | 320,388 | $4.00 | $1.28M | 145,548 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | X Exercise | 2021-06-09 | 2021-06-11 | 1,602,888 | $2.75 | $4.41M | 1,602,888 | SEC↗ |
| ARYA ARYA Sciences Acquisition | P Buy | 2021-06-03 | 2021-06-03 | 330,050 | $10.05 | $3.32M | 489,975 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2021-05-28 | 2021-06-01 | 13,871 | — | $0 | 13,871 | SEC↗ |
| NAUT Nautilus Biotechnology, In | P Buy | 2021-05-24 | 2021-06-11 | 7,063 | $10.05 | $71.0K | 497,038 | SEC↗ |
| ARYA ARYA Sciences Acquisition | P Buy | 2021-05-20 | 2021-05-24 | 159,925 | $10.05 | $1.61M | 159,925 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | S Sale | 2021-05-06 | 2021-05-07 | 1,000,000 | $3.67 | $3.67M | 5,773,954 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2021-05-03 | 2021-05-04 | 1,200,000 | $12.50 | $15.00M | 9,903,879 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 1,195,792 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 949,992 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-27 | 2021-04-27 | 550,000 | $17.00 | $9.35M | 2,537,019 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-27 | 1,107,316 | — | $0 | 1,987,019 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-27 | 879,703 | — | $0 | 879,703 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2021-04-08 | 2021-04-09 | 304,136 | $16.44 | $5.00M | 3,963,517 | SEC↗ |
| SLDB Solid Biosciences Inc. | P Buy | 2021-03-23 | 2021-03-23 | 2,608,695 | $5.75 | $15.00M | 13,412,552 | SEC↗ |
| RXDX Prometheus Biosciences, In | C Conversion deriv | 2021-03-16 | 2021-03-16 | 10,177,703 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | C Conversion deriv | 2021-03-16 | 2021-03-16 | 14,462,623 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | C Conversion | 2021-03-16 | 2021-03-16 | 1,446,262 | — | $0 | 2,464,032 | SEC↗ |
| RXDX Prometheus Biosciences, In | P Buy | 2021-03-16 | 2021-03-16 | 850,000 | $19.00 | $16.15M | 3,314,032 | SEC↗ |
| RXDX Prometheus Biosciences, In | C Conversion | 2021-03-16 | 2021-03-16 | 1,017,770 | — | $0 | 1,017,770 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | J Other deriv | 2021-02-26 | 2021-04-06 | 450,000 | — | $0 | 450,000 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 34,951 | $14.60 | $510.3K | 7,299,751 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 64,730 | $13.80 | $893.3K | 7,264,800 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-08 | 1,770,600 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 5,799,564 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 2,941,769 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 1,770,600 | — | $0 | 1,770,600 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-08 | 1,250,000 | $16.00 | $20.00M | 7,049,564 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,857,795 | — | $0 | 5,799,564 | SEC↗ |
| LABP Landos Biopharma, Inc. | C Conversion | 2021-02-08 | 2021-02-08 | 2,941,769 | — | $0 | 2,941,769 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-09 | 1,771 | $13.10 | $23.2K | 7,200,070 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-09 | 86,671 | $12.53 | $1.09M | 7,198,299 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-08 | 2021-02-09 | 34,611 | $11.38 | $393.9K | 7,111,628 | SEC↗ |
| LABP Landos Biopharma, Inc. | P Buy | 2021-02-05 | 2021-02-09 | 27,453 | $11.14 | $305.8K | 7,077,017 | SEC↗ |